Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
31-45 of 437
Supportive Care Before CLL Treatment: Infection Risk and Comorbidity Management
Project Oncology®Supportive Care Before CLL Treatment: Infection Risk and Comorbidity Management
Kerry A. Rogers, MD
How Myeloid Mutations in ALL Inform Treatment Decisions
Project Oncology®How Myeloid Mutations in ALL Inform Treatment Decisions
Caner Saygin, MD
Supportive Care During and After CLL Treatment: What to Prioritize
Project Oncology®Supportive Care During and After CLL Treatment: What to Prioritize
Kerry A. Rogers, MD
Key Questions Shaping Chemotherapy-Free Treatment in Mantle Cell Lymphoma
Project Oncology®Key Questions Shaping Chemotherapy-Free Treatment in Mantle Cell Lymphoma
Jonathon B. Cohen, MD, MS
Resistance and Transformation in EGFR-Mutant Lung Cancer
Project Oncology®Resistance and Transformation in EGFR-Mutant Lung Cancer
Triparna Sen, PhD
A Look at WCLC 2026: Pivotal Trials and Emerging Directions
Project Oncology®A Look at WCLC 2026: Pivotal Trials and Emerging Directions
Triparna Sen, PhD
- advertisement
Making the Most of WCLC 2026: A Guide for Early-Career Professionals
Project Oncology®Making the Most of WCLC 2026: A Guide for Early-Career Professionals
Triparna Sen, PhD
Closing the Evidence Gap in Metastasis-Directed Therapy for mBC
Project Oncology®Closing the Evidence Gap in Metastasis-Directed Therapy for mBC
Lajos Pusztai, MD, DPhil
Is There a Role for Primary Tumor Surgery in Metastatic Breast Cancer?
Project Oncology®Is There a Role for Primary Tumor Surgery in Metastatic Breast Cancer?
Lajos Pusztai, MD, DPhil
Exploring Combination Treatment in ER+/HER2- Breast Cancer
Project Oncology®Exploring Combination Treatment in ER+/HER2- Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP
Wassim Mchayleh, MD, MBA, FACP
Emerging Endpoints for Evaluating Treatment Benefit in pLGG
Project Oncology®Emerging Endpoints for Evaluating Treatment Benefit in pLGG
Shelina Ramnarine, PhD
Mohamed Abdelbaki, MD
3-Year FIREFLY-1 Findings in pLGG: A Look at Long-Term Outcomes
Project Oncology®3-Year FIREFLY-1 Findings in pLGG: A Look at Long-Term Outcomes
Alexandria May, PharmD, BCPS
Daniel Landi, MD
- advertisement
Monitoring Toxicities During Advanced Urothelial Carcinoma Treatment
Project Oncology®Monitoring Toxicities During Advanced Urothelial Carcinoma Treatment
Petros Grivas, MD, PhD
What’s Behind the Toxicity? Key Clues in Urothelial Carcinoma
Project Oncology®What’s Behind the Toxicity? Key Clues in Urothelial Carcinoma
Petros Grivas, MD, PhD
Supporting Patients Throughout Urothelial Carcinoma Treatment
Project Oncology®Supporting Patients Throughout Urothelial Carcinoma Treatment
Petros Grivas, MD, PhD